Open Redirect in Clinical-Genomics Scout
CVE-2024-47530
Scout is a web-based visualizer for VCF-files. Open redirect vulnerability allows performing phishing attacks on users by redirecting them to malicious page. /login API endpoint is vulnerable to open redirect attack via next parameter due to absence of sanitization logic. Additionally, due to lack of scheme validation, HTTPS Downgrade Attack can be performed on the users. This vulnerability is fixed in 4.89.
Vulnerability class: Open Redirect
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N.
EPSS exploit prediction
EPSS: 0.004 (31.0th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 31st percentile — 31.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: +0.000
Affected products
- Clinical-Genomics Scout — versions < 4.89
Weakness classification (CWE)
Public proof-of-concept exploits
References
- github.com/Clinical-Genomics/scout/security/advisories/GHSA-3x45-2m34-x95v (Exploit, Third Party Advisory)
- github.com/Clinical-Genomics/scout/commit/50055edfca9a7183b248019af97e1fb0b0065… (Patch)
Frequently asked questions
- What is CVE-2024-47530?
- CVE-2024-47530 is a medium-severity vulnerability in Clinical-Genomics Scout, classified under URL Redirection to Untrusted Site (Open Redirect). CVSS score: 5.4/10. Published 2024-09-30.
- How severe is CVE-2024-47530?
- Medium severity. CVSS v3 base score is 5.4 out of 10.
- Is CVE-2024-47530 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.